- Report
- January 2025
- 179 Pages
Global
From €4250EUR$4,500USD£3,615GBP
- Report
- April 2025
- 50 Pages
Global
From €2503EUR$2,650USD£2,129GBP
Triclabendazole is an anthelmintic drug used to treat a variety of parasitic infections caused by flatworms. It is used to treat infections caused by Fasciola hepatica, Fasciolopsis buski, and other trematodes. It is also used to treat infections caused by Paragonimus westermani, a type of lung fluke. Triclabendazole is a member of the benzimidazole family of drugs, which are used to treat a variety of parasitic infections. Triclabendazole is available in tablet, suspension, and injectable forms.
Triclabendazole is used in the treatment of a variety of infectious diseases, including schistosomiasis, fascioliasis, paragonimiasis, and clonorchiasis. It is also used to treat infections caused by other trematodes, such as Echinostoma spp. and Fasciolopsis buski. Triclabendazole is also used to treat infections caused by other parasites, such as hookworms, roundworms, and whipworms.
Triclabendazole is available from a number of pharmaceutical companies, including Merck, Pfizer, Sanofi, and Novartis. It is also available from generic drug manufacturers, such as Mylan, Teva, and Sandoz. Show Less Read more